Join as a Volunteer
MARC
MARC for Medical Services and Scientific Research is an integrative research center that aims to advance science by conducting research in interdisciplinary disease areas. Our goal is to conduct high-priority and ethical basic, preclinical and clinical research, bridging the gap between science and community to improve health and quality of life.
Contract Research Organization
Bioscience Research Laboratories
Bioequivalence Center
Featured Studies
Contract Research Organization
EgyVax-Phase I study
This is a Phase I, prospective, three-arm, open-label, randomized, first-in-human (FIH) clinical trial to assess the safety and immunogenicity of EgyVax vaccine candidate for prophylaxis of SARS-CoV-2 infection (COVID-19).
,
Grant-winning projects
Immunotherapy: Interference with the immune-tumor interface by small organic molecules: Aa new modality for the treatment of cancer - Primary investigator: Prof. Dr. Ashraf Abadi - Head of Pharmaceutical Chemistry Department, Faculty of Pharmacy and Biotechnology, German University in Cairo.
,
Grant-winning projects
NASH: Transcriptional profile and machine learning models as potential tools for non-invasive diagnostic and prediction of drug efficacy in non-alcoholic steatohepatitis (NASH) -Primary investigator: Dr. Marwa Matbouli - Associate Professor of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Ain Shams University
Grant-winning projects
Multi-drug resistance: The effect of ladybirds’ antimicrobial peptides on multidrug-resistant bacteria and enteric viruses - Primary investigator: Prof. Dr. Ahmed Abdou Sherif - Dean of Faculty of Science, Cairo University
Bioequivalence Services
All services are conducted under the supervision of the quality assurance team to ensure that all study activities comply with ISO 9001:2015, local and international regulations (GLP, GCP, and GDocP), in-house policies, and standard operating procedures.
Conducting bioequivalence and bioanalysis studies
Conducting comparative dissolution studies
Collecting, analyzing, and archiving raw data for all studies conducted by MARC-BE
Conducting pharmacokinetic studies
Statistical analysis services
Performing pharmacokinetic calculations
Sample size calculation and developing randomization plans
Developing study protocol synopsis
Writing full study protocols and amendments
Writing informed consent forms
Generating bioequivalence study reports
Writing scientific reports, including pharmacokinetic reports, bioanalytical reports, and biostatistical reports
Submission to ethical review boards
Attending meetings with ethical review boards
Documenting and archiving clinical study procedures and results
Grant Programs
• In 2022, MARC offered five research grants in three health areas: immunotherapy and cancer research, NASH, and infections by MDR pathogens. • The funding was up to EGP 3 million for each proposal • MARC will offer more grants in these health areas in 2025. Stay tuned!
"Turning breakthroughs into real world medical solutions for improving lives"
A newly established integrative research center that aims to advance science by conducting research into interdisciplinary disease areas
Subscribe for our latest news and updates
Follow Us
